1h Free Analyst Time
This report offers market size & forecast data for the US clinical trial support services market. The revenue generated from services offered for phase 1, phase II, phase III & phase IV stages of development are included in the report. Revenue generated from services offered for discovery, pre-clinical, and phase 0 stages of development are excluded from the report. This report provides a comprehensive and current market scenario of the US clinical trial support services market, including the US clinical trial support services market size, anticipated market forecast, relevant market segmentations, and industry trends. Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present clinical trial support services market and its market dynamics for 2023−2028 in the US. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
Key Highlights
- In the US, the clinical trial support services market was valued at $7.43 billion in 2022 and is expected to reach $10.44 billion by 2028, growing at a CAGR of 5.84%. The demand for clinical trial support services market is on the rise due to multiple factors, including a surge in R&D activities, the high prevalence of chronic diseases, and the adoption of clinical trial support services.
- By Service type, the site management systems accounted for the highest share of 43.03% in 2022 and is projected to grow at the highest CAGR of 5.37% during the forecast period. The increasing demand for site management systems is due to the rising disease burden, increasing prevalence of chronic diseases, and increasing number of clinical trials.
- By Phase, the Phase III segment accounted for the highest share of 45.55% in 2022 and is projected to grow at the highest CAGR of 6.19% during the forecast period. The rise in the number of clinical trials and the high prevalence of chronic diseases, among others, is expected to contribute to the growth of the overall clinical trial support services market.
- In End-user type, the pharma & biotech companies segment accounted for the highest share of 66.32% in 2022 and is projected to grow at the highest CAGR of 5.50% during the forecast period. The high prevalence of chronic diseases and increasing R&D expenditure by pharma & biotech companies will drive the growth of the market
- By Application, the cancer segment accounted for the highest share of 33.64% in 2022 and is projected to grow at the highest CAGR of 6.14% during the forecast period. The rising prevalence of cancer conditions, demand for clinical trials, and constant increase in cancer patients are some of the factors that propel the segment growth.
- Charles River Laboratories, IQVIA Inc, Icon plc, Labcorp Drug Development, and Syneos Health are some of the leading players currently dominating the US clinical trial support services market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the clinical trial support services market.
VENDORS LIST
- Charles River Laboratories
- IQVIA Inc
- Icon plc
- Labcorp Drug Development
- Syneos Health
- Thermo Fisher Scientific
- WuXi AppTec
- Paraxel
- Advanced Clinical
- ProtaGene
- Curia Global
- Aixial Group
- Cromos Pharma
- Criterium
- KCR S.A.
- Medpace
- Medelis
- Worldwide Clinical Trials
- Sofpromed
- Veristat
PRODUCT SEGMENTATION & FORECAST
By Service
- Site Management
- Recruitment Management
- Data Management
- Institutional Review Board
- Others
By Phase
- Phase III
- Phase II
- Phase IV
- Phase I
End-user
- Pharmaceutical & Biotech Companies
- Medical Device Companies
- Others
By Application
- Cancer
- Cardiovascular Diseases
- Nervous System Diseases
- Infectious Diseases
- Musculo-skeletal Diseases
- Gastroenterology Diseases
- Others
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of Clinical Trial Support Services Market
- Key Vendors
- Other Prominent Vendors
APPENDIX
- Research Methodology
- Abbreviations
Table of Contents
Chapter - 1: Clinical Trial Support Services Market Overview
Chapter - 2: Clinical Trial Support Services Market
Chapter - 3: Clinical Trial Support Services Market Segmentation Data
Chapter - 4: Clinical Trial Support Services Market Prospects & Opportunities
Chapter - 5: Clinical Trial Support Services Industry Overview
Chapter - 6: Appendix
List of Exhibits
List of Tables
Companies Mentioned
- Charles River Laboratories
- IQVIA Inc.
- Icon PLC
- Labcorp Drug Development
- Syneos Health
- Thermo Fisher Scientific
- WuXi AppTec
- Paraxel
- Advanced Clinical
- ProtaGene
- Curia Global
- Aixial Group
- Cromos Pharma
- Criterium
- KCR SA
- Medpace
- Medelis
- Worldwide Clinical Trials
- Sofpromed
- Veristat
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 97 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 7.43 Billion |
| Forecasted Market Value ( USD | $ 10.44 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | United States |
| No. of Companies Mentioned | 20 |
